Funding for this research was provided by:
Fighting Duchenne Foundation
Alzheimer's Disease Research Center, Emory University
NHLBI Division of Intramural Research (R56HL141248, K23HL123938, K08HL155852, 5T32HL105334-10)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD087023)
U.S. Food and Drug Administration (R01FD006649)
National Center for Advancing Translational Sciences (2 UL1 TR000445-06)
Received: 3 November 2022
Accepted: 30 June 2023
First Online: 31 July 2023
: Ethical approval was obtained and all participants gave informed consent.
: No identifiable individual information was included in this study.
: The authors declare that they have no competing interests.